Antihormonal Cancer Therapies Market, Global Outlook and Forecast 2023-2028

Report ID: 1632830 | Published Date: Jan 2025 | No. of Page: 65 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Antihormonal Cancer Therapies Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Antihormonal Cancer Therapies Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Antihormonal Cancer Therapies Overall Market Size
    2.1 Global Antihormonal Cancer Therapies Market Size: 2021 VS 2028
    2.2 Global Antihormonal Cancer Therapies Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Antihormonal Cancer Therapies Players in Global Market
    3.2 Top Global Antihormonal Cancer Therapies Companies Ranked by Revenue
    3.3 Global Antihormonal Cancer Therapies Revenue by Companies
    3.4 Top 3 and Top 5 Antihormonal Cancer Therapies Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Antihormonal Cancer Therapies Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Antihormonal Cancer Therapies Players in Global Market
        3.6.1 List of Global Tier 1 Antihormonal Cancer Therapies Companies
        3.6.2 List of Global Tier 2 and Tier 3 Antihormonal Cancer Therapies Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Antihormonal Cancer Therapies Market Size Markets, 2021 & 2028
        4.1.2 Radiations
        4.1.3 Drugs
        4.1.4 Surgeries
        4.1.5 Others
    4.2 By Type - Global Antihormonal Cancer Therapies Revenue & Forecasts
        4.2.1 By Type - Global Antihormonal Cancer Therapies Revenue, 2017-2022
        4.2.2 By Type - Global Antihormonal Cancer Therapies Revenue, 2023-2028
        4.2.3 By Type - Global Antihormonal Cancer Therapies Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Antihormonal Cancer Therapies Market Size, 2021 & 2028
        5.1.2 Breast Cancer
        5.1.3 Prostate Cancer
        5.1.4 Other
    5.2 By Application - Global Antihormonal Cancer Therapies Revenue & Forecasts
        5.2.1 By Application - Global Antihormonal Cancer Therapies Revenue, 2017-2022
        5.2.2 By Application - Global Antihormonal Cancer Therapies Revenue, 2023-2028
        5.2.3 By Application - Global Antihormonal Cancer Therapies Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Antihormonal Cancer Therapies Market Size, 2021 & 2028
    6.2 By Region - Global Antihormonal Cancer Therapies Revenue & Forecasts
        6.2.1 By Region - Global Antihormonal Cancer Therapies Revenue, 2017-2022
        6.2.2 By Region - Global Antihormonal Cancer Therapies Revenue, 2023-2028
        6.2.3 By Region - Global Antihormonal Cancer Therapies Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Antihormonal Cancer Therapies Revenue, 2017-2028
        6.3.2 US Antihormonal Cancer Therapies Market Size, 2017-2028
        6.3.3 Canada Antihormonal Cancer Therapies Market Size, 2017-2028
        6.3.4 Mexico Antihormonal Cancer Therapies Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Antihormonal Cancer Therapies Revenue, 2017-2028
        6.4.2 Germany Antihormonal Cancer Therapies Market Size, 2017-2028
        6.4.3 France Antihormonal Cancer Therapies Market Size, 2017-2028
        6.4.4 U.K. Antihormonal Cancer Therapies Market Size, 2017-2028
        6.4.5 Italy Antihormonal Cancer Therapies Market Size, 2017-2028
        6.4.6 Russia Antihormonal Cancer Therapies Market Size, 2017-2028
        6.4.7 Nordic Countries Antihormonal Cancer Therapies Market Size, 2017-2028
        6.4.8 Benelux Antihormonal Cancer Therapies Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Antihormonal Cancer Therapies Revenue, 2017-2028
        6.5.2 China Antihormonal Cancer Therapies Market Size, 2017-2028
        6.5.3 Japan Antihormonal Cancer Therapies Market Size, 2017-2028
        6.5.4 South Korea Antihormonal Cancer Therapies Market Size, 2017-2028
        6.5.5 Southeast Asia Antihormonal Cancer Therapies Market Size, 2017-2028
        6.5.6 India Antihormonal Cancer Therapies Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Antihormonal Cancer Therapies Revenue, 2017-2028
        6.6.2 Brazil Antihormonal Cancer Therapies Market Size, 2017-2028
        6.6.3 Argentina Antihormonal Cancer Therapies Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Antihormonal Cancer Therapies Revenue, 2017-2028
        6.7.2 Turkey Antihormonal Cancer Therapies Market Size, 2017-2028
        6.7.3 Israel Antihormonal Cancer Therapies Market Size, 2017-2028
        6.7.4 Saudi Arabia Antihormonal Cancer Therapies Market Size, 2017-2028
        6.7.5 UAE Antihormonal Cancer Therapies Market Size, 2017-2028
7 Players Profiles
    7.1 AstraZeneca
        7.1.1 AstraZeneca Corporate Summary
        7.1.2 AstraZeneca Business Overview
        7.1.3 AstraZeneca Antihormonal Cancer Therapies Major Product Offerings
        7.1.4 AstraZeneca Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.1.5 AstraZeneca Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Antihormonal Cancer Therapies Major Product Offerings
        7.2.4 Novartis Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Pfizer
        7.3.1 Pfizer Corporate Summary
        7.3.2 Pfizer Business Overview
        7.3.3 Pfizer Antihormonal Cancer Therapies Major Product Offerings
        7.3.4 Pfizer Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.3.5 Pfizer Key News
    7.4 Sanofi
        7.4.1 Sanofi Corporate Summary
        7.4.2 Sanofi Business Overview
        7.4.3 Sanofi Antihormonal Cancer Therapies Major Product Offerings
        7.4.4 Sanofi Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.4.5 Sanofi Key News
    7.5 Takeda
        7.5.1 Takeda Corporate Summary
        7.5.2 Takeda Business Overview
        7.5.3 Takeda Antihormonal Cancer Therapies Major Product Offerings
        7.5.4 Takeda Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.5.5 Takeda Key News
    7.6 Roche
        7.6.1 Roche Corporate Summary
        7.6.2 Roche Business Overview
        7.6.3 Roche Antihormonal Cancer Therapies Major Product Offerings
        7.6.4 Roche Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.6.5 Roche Key News
    7.7 Amgen
        7.7.1 Amgen Corporate Summary
        7.7.2 Amgen Business Overview
        7.7.3 Amgen Antihormonal Cancer Therapies Major Product Offerings
        7.7.4 Amgen Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.7.5 Amgen Key News
    7.8 Samyang Biopharmaceuticals
        7.8.1 Samyang Biopharmaceuticals Corporate Summary
        7.8.2 Samyang Biopharmaceuticals Business Overview
        7.8.3 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Major Product Offerings
        7.8.4 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.8.5 Samyang Biopharmaceuticals Key News
    7.9 Tolmar
        7.9.1 Tolmar Corporate Summary
        7.9.2 Tolmar Business Overview
        7.9.3 Tolmar Antihormonal Cancer Therapies Major Product Offerings
        7.9.4 Tolmar Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.9.5 Tolmar Key News
    7.10 Bluebird Bio
        7.10.1 Bluebird Bio Corporate Summary
        7.10.2 Bluebird Bio Business Overview
        7.10.3 Bluebird Bio Antihormonal Cancer Therapies Major Product Offerings
        7.10.4 Bluebird Bio Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.10.5 Bluebird Bio Key News
    7.11 Bristol-Myers Squibb
        7.11.1 Bristol-Myers Squibb Corporate Summary
        7.11.2 Bristol-Myers Squibb Business Overview
        7.11.3 Bristol-Myers Squibb Antihormonal Cancer Therapies Major Product Offerings
        7.11.4 Bristol-Myers Squibb Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.11.5 Bristol-Myers Squibb Key News
    7.12 Exelixis
        7.12.1 Exelixis Corporate Summary
        7.12.2 Exelixis Business Overview
        7.12.3 Exelixis Antihormonal Cancer Therapies Major Product Offerings
        7.12.4 Exelixis Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.12.5 Exelixis Key News
    7.13 Guardant Health
        7.13.1 Guardant Health Corporate Summary
        7.13.2 Guardant Health Business Overview
        7.13.3 Guardant Health Antihormonal Cancer Therapies Major Product Offerings
        7.13.4 Guardant Health Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.13.5 Guardant Health Key News
    7.14 Illumina
        7.14.1 Illumina Corporate Summary
        7.14.2 Illumina Business Overview
        7.14.3 Illumina Antihormonal Cancer Therapies Major Product Offerings
        7.14.4 Illumina Antihormonal Cancer Therapies Revenue in Global Market (2017-2022)
        7.14.5 Illumina Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Antihormonal Cancer Therapies Market Opportunities & Trends in Global Market
    Table 2. Antihormonal Cancer Therapies Market Drivers in Global Market
    Table 3. Antihormonal Cancer Therapies Market Restraints in Global Market
    Table 4. Key Players of Antihormonal Cancer Therapies in Global Market
    Table 5. Top Antihormonal Cancer Therapies Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Antihormonal Cancer Therapies Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Antihormonal Cancer Therapies Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Antihormonal Cancer Therapies Product Type
    Table 9. List of Global Tier 1 Antihormonal Cancer Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Antihormonal Cancer Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Antihormonal Cancer Therapies Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Antihormonal Cancer Therapies Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Antihormonal Cancer Therapies Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Antihormonal Cancer Therapies Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Antihormonal Cancer Therapies Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Antihormonal Cancer Therapies Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Antihormonal Cancer Therapies Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Antihormonal Cancer Therapies Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Antihormonal Cancer Therapies Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Antihormonal Cancer Therapies Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Antihormonal Cancer Therapies Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Antihormonal Cancer Therapies Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Antihormonal Cancer Therapies Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Antihormonal Cancer Therapies Revenue, (US$, Mn), 2023-2028
    Table 30. AstraZeneca Corporate Summary
    Table 31. AstraZeneca Antihormonal Cancer Therapies Product Offerings
    Table 32. AstraZeneca Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis Antihormonal Cancer Therapies Product Offerings
    Table 35. Novartis Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
    Table 36. Pfizer Corporate Summary
    Table 37. Pfizer Antihormonal Cancer Therapies Product Offerings
    Table 38. Pfizer Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
    Table 39. Sanofi Corporate Summary
    Table 40. Sanofi Antihormonal Cancer Therapies Product Offerings
    Table 41. Sanofi Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
    Table 42. Takeda Corporate Summary
    Table 43. Takeda Antihormonal Cancer Therapies Product Offerings
    Table 44. Takeda Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
    Table 45. Roche Corporate Summary
    Table 46. Roche Antihormonal Cancer Therapies Product Offerings
    Table 47. Roche Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
    Table 48. Amgen Corporate Summary
    Table 49. Amgen Antihormonal Cancer Therapies Product Offerings
    Table 50. Amgen Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
    Table 51. Samyang Biopharmaceuticals Corporate Summary
    Table 52. Samyang Biopharmaceuticals Antihormonal Cancer Therapies Product Offerings
    Table 53. Samyang Biopharmaceuticals Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
    Table 54. Tolmar Corporate Summary
    Table 55. Tolmar Antihormonal Cancer Therapies Product Offerings
    Table 56. Tolmar Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
    Table 57. Bluebird Bio Corporate Summary
    Table 58. Bluebird Bio Antihormonal Cancer Therapies Product Offerings
    Table 59. Bluebird Bio Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
    Table 60. Bristol-Myers Squibb Corporate Summary
    Table 61. Bristol-Myers Squibb Antihormonal Cancer Therapies Product Offerings
    Table 62. Bristol-Myers Squibb Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
    Table 63. Exelixis Corporate Summary
    Table 64. Exelixis Antihormonal Cancer Therapies Product Offerings
    Table 65. Exelixis Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
    Table 66. Guardant Health Corporate Summary
    Table 67. Guardant Health Antihormonal Cancer Therapies Product Offerings
    Table 68. Guardant Health Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
    Table 69. Illumina Corporate Summary
    Table 70. Illumina Antihormonal Cancer Therapies Product Offerings
    Table 71. Illumina Antihormonal Cancer Therapies Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Antihormonal Cancer Therapies Segment by Type in 2021
    Figure 2. Antihormonal Cancer Therapies Segment by Application in 2021
    Figure 3. Global Antihormonal Cancer Therapies Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Antihormonal Cancer Therapies Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Antihormonal Cancer Therapies Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Antihormonal Cancer Therapies Revenue in 2021
    Figure 8. By Type - Global Antihormonal Cancer Therapies Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Antihormonal Cancer Therapies Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Antihormonal Cancer Therapies Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Antihormonal Cancer Therapies Revenue Market Share, 2017-2028
    Figure 12. US Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Antihormonal Cancer Therapies Revenue Market Share, 2017-2028
    Figure 16. Germany Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 17. France Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Antihormonal Cancer Therapies Revenue Market Share, 2017-2028
    Figure 24. China Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 28. India Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Antihormonal Cancer Therapies Revenue Market Share, 2017-2028
    Figure 30. Brazil Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Antihormonal Cancer Therapies Revenue Market Share, 2017-2028
    Figure 33. Turkey Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Antihormonal Cancer Therapies Revenue, (US$, Mn), 2017-2028
    Figure 37. AstraZeneca Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Pfizer Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Sanofi Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Takeda Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Roche Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Amgen Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Samyang Biopharmaceuticals Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Tolmar Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Bluebird Bio Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Bristol-Myers Squibb Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Exelixis Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Guardant Health Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Illumina Antihormonal Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
65
Frequently Asked Questions
Antihormonal Cancer Therapies Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antihormonal Cancer Therapies Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antihormonal Cancer Therapies Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports